Free Trial

Vivos (OTCMKTS:RDGL) Trading Down 0.2% - Should You Sell?

Vivos logo with Finance background

Vivos Inc. (OTCMKTS:RDGL - Get Free Report)'s share price dropped 0.2% during mid-day trading on Wednesday . The company traded as low as $0.13 and last traded at $0.13. Approximately 478,156 shares were traded during trading, a decline of 48% from the average daily volume of 923,381 shares. The stock had previously closed at $0.13.

Vivos Price Performance

The business's 50 day moving average price is $0.12 and its 200-day moving average price is $0.12. The firm has a market capitalization of $58.46 million, a price-to-earnings ratio of -12.89 and a beta of 1.06.

About Vivos

(Get Free Report)

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.

Recommended Stories

Should You Invest $1,000 in Advanced Medical Isotope Right Now?

Before you consider Advanced Medical Isotope, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Advanced Medical Isotope wasn't on the list.

While Advanced Medical Isotope currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines